NCT03475277View on ClinicalTrials.gov

Stanford Regulating Circuits of the Brain Study- Ketamine

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

August 19, 2019

Primary Completion Date

November 30, 2022

Study Completion Date

July 1, 2024

Conditions
Healthy
Interventions
DRUG

Ketamine

Acute administration

Trial Locations (1)

94304

Stanford Psychiatry, Palo Alto

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Stanford University

OTHER

NCT03475277 - Stanford Regulating Circuits of the Brain Study- Ketamine | Biotech Hunter | Biotech Hunter